Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
Public ClinicalTrials.gov record NCT00369837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Effect of Ultrashort-Acting Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine the safety of clevidipine for treating severely elevated blood pressure, defined as systolic (SBP) \>180 mmHg and/or diastolic blood pressure (DBP) \>115 mmHg assessed on 2 successive occasions 15 minutes apart at baseline, in patients with or without major organ injury, particularly with respect to controlled dose adjustment to desired effect and prolonged continuous infusion. Enrollment of patients into the study was to continue until the target goal of 100 patients with at least 18 hours of continuous clevidipine treatment, including a minimum of 50 patients with acute or chronic end-organ injury, was met.
Study identification
- NCT ID
- NCT00369837
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Dec 31, 2006
- Completion
- Jan 31, 2007
- Last update posted
- May 21, 2014
2006 – 2007
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jackson Hospital | Montgomery | Alabama | 36106 | — |
| VA Medical Center W. LA | Los Angeles | California | 90073 | — |
| The George Washington University Medical Center | Washington D.C. | District of Columbia | 20037 | — |
| Louisiana State University Medical Center/Charity Hospital | New Orleans | Louisiana | 70118 | — |
| Critical Care Research Center at Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| Good Samaritan Hospital | Baltimore | Maryland | 21239 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Metrohealth Medical Center | Cleveland | Ohio | 44109 | — |
| The Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| The Toledo Hospital | Toledo | Ohio | 43606 | — |
| Providence Heart & Vascular Institute, d/b/a Providence St. Vincent Medical Center | Portland | Oregon | 97225 | — |
| Hamot Shock Trauma | Erie | Pennsylvania | 16550 | — |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19107 | — |
| The University of Texas Health Science Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00369837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2014 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00369837 live on ClinicalTrials.gov.